Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
About this item
Full title
Author / Creator
Loupakis, Fotios , Cremolini, Chiara , Masi, Gianluca , Lonardi, Sara , Zagonel, Vittorina , Salvatore, Lisa , Cortesi, Enrico , Tomasello, Gianluca , Ronzoni, Monica , Spadi, Rosella , Zaniboni, Alberto , Tonini, Giuseppe , Buonadonna, Angela , Amoroso, Domenico , Chiara, Silvana , Carlomagno, Chiara , Boni, Corrado , Allegrini, Giacomo , Boni, Luca and Falcone, Alfredo
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus bevacizumab, improved progression-free and overall survival, with an increase in some side effects.
Alternative Titles
Full title
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
Authors, Artists and Contributors
Author / Creator
Cremolini, Chiara
Masi, Gianluca
Lonardi, Sara
Zagonel, Vittorina
Salvatore, Lisa
Cortesi, Enrico
Tomasello, Gianluca
Ronzoni, Monica
Spadi, Rosella
Zaniboni, Alberto
Tonini, Giuseppe
Buonadonna, Angela
Amoroso, Domenico
Chiara, Silvana
Carlomagno, Chiara
Boni, Corrado
Allegrini, Giacomo
Boni, Luca
Falcone, Alfredo
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1615783785
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1615783785
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1403108
